BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 16386568)

  • 1. Safety of percutaneous ethanol injection as neoadjuvant therapy for hepatocellular carcinoma in waiting list liver transplant candidates.
    Castroagudín JF; Delgado M; Villanueva A; Bustamante M; Martínez J; Otero E; Tomé S; Martínez SM; Segade FR; Conde R; Dominguez-Muñoz E; Varo E
    Transplant Proc; 2005 Nov; 37(9):3871-3. PubMed ID: 16386568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective histopathological analysis of hepatocellular carcinoma treated with percutaneous ethanol injection in patients on the waiting list for liver transplantation.
    Castroagudin JF; Delgado M; Martinez SM; Abdulkader I; Potel J; Tome S; Otero E; Varo E
    Transplant Proc; 2005 Apr; 37(3):1477-9. PubMed ID: 15866645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long term results of single session percutaneous ethanol injection in patients with large hepatocellular carcinoma.
    Livraghi T; Benedini V; Lazzaroni S; Meloni F; Torzilli G; Vettori C
    Cancer; 1998 Jul; 83(1):48-57. PubMed ID: 9655292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of hepatocellular carcinoma locoregional therapies on patients waiting for liver transplantation.
    Moreno Planas JM; López Monclús J; Gómez Cruz A; Rubio González E; Pérez Arangüena R; Boullosa Graña E; Garcia Suárez A; Pérez-Picouto JL; Fernández Ruiz M; Lucena de la Poza JL; Sánchez Turrión V; Cuervas-Mons Martínez V
    Transplant Proc; 2005 Apr; 37(3):1484-5. PubMed ID: 15866648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation.
    Lu DS; Yu NC; Raman SS; Lassman C; Tong MJ; Britten C; Durazo F; Saab S; Han S; Finn R; Hiatt JR; Busuttil RW
    Hepatology; 2005 May; 41(5):1130-7. PubMed ID: 15841454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of transarterial chemoembolization for hepatocellular carcinoma before liver transplantation with special consideration of tumor necrosis.
    Schaudt A; Kriener S; Schwarz W; Wullstein C; Zangos S; Vogl T; Mehrabi A; Fonouni H; Bechstein WO; Golling M
    Clin Transplant; 2009 Dec; 23 Suppl 21():61-7. PubMed ID: 19930318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival of cirrhotic patients with early hepatocellular carcinoma treated by percutaneous ethanol injection or liver transplantation.
    Andriulli A; de Sio I; Solmi L; De Carlis L; Troisi R; Grasso A; Festa V; Caturelli E; Giacomoni A; Del Vecchio Blanco C; De Hemptinne B; Burroughs A; Perri F
    Liver Transpl; 2004 Nov; 10(11):1355-63. PubMed ID: 15497162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: Assessment of efficacy at explant analysis and of safety for tumor recurrence.
    Pompili M; Mirante VG; Rondinara G; Fassati LR; Piscaglia F; Agnes S; Covino M; Ravaioli M; Fagiuoli S; Gasbarrini G; Rapaccini GL
    Liver Transpl; 2005 Sep; 11(9):1117-26. PubMed ID: 16123960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Needle tract implantation of hepatocellular carcinoma after percutaneous ethanol injection.
    Ishii H; Okada S; Okusaka T; Yoshimori M; Nakasuka H; Shimada K; Yamasaki S; Nakanishi Y; Sakamoto M
    Cancer; 1998 May; 82(9):1638-42. PubMed ID: 9576282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atropine for prevention of cardiac dysrhythmias in patients with hepatocellular carcinoma undergoing percutaneous ethanol instillation: a randomized, placebo-controlled, double-blind trial.
    Arnulf F; Monika S; Herwig S; Monika H; Johannes PD; Gregor U; Alfred G; Markus PR
    Liver Int; 2009 May; 29(5):715-20. PubMed ID: 19018977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-transplant treatment of hepatocellular carcinoma: assessment of tumor necrosis in explanted livers.
    Wong LL; Tanaka K; Lau L; Komura S
    Clin Transplant; 2004 Jun; 18(3):227-34. PubMed ID: 15142041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cutaneous seeding after ultrasound-guided percutaneous ethanol injection for treatment of hepatocellular carcinoma.
    Casella G; Cacopardo E; Rovere G; Buda CA; Cascinu S; Baldini V
    J Clin Ultrasound; 2001; 29(6):354-8. PubMed ID: 11424102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list.
    Yao FY; Bass NM; Nikolai B; Davern TJ; Kerlan R; Wu V; Ascher NL; Roberts JP
    Liver Transpl; 2002 Oct; 8(10):873-83. PubMed ID: 12360427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination therapy of percutaneous ethanol injection and radiofrequency ablation against hepatocellular carcinomas difficult to treat.
    Kurokohchi K; Watanabe S; Masaki T; Hosomi N; Funaki T; Arima K; Yoshida S; Nakai S; Murota M; Miyauchi Y; Kuriyama S
    Int J Oncol; 2002 Sep; 21(3):611-5. PubMed ID: 12168107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of clinical outcomes in chronic hepatitis B liver transplant candidates with and without hepatocellular carcinoma.
    Wong SN; Reddy KR; Keeffe EB; Han SH; Gaglio PJ; Perrillo RP; Tran TT; Pruett TL; Lok AS
    Liver Transpl; 2007 Mar; 13(3):334-42. PubMed ID: 17154401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An analysis of resection vs transplantation for early hepatocellular carcinoma: defining the optimal therapy at a single institution.
    Shah SA; Cleary SP; Tan JC; Wei AC; Gallinger S; Grant DR; Greig PD
    Ann Surg Oncol; 2007 Sep; 14(9):2608-14. PubMed ID: 17522942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local recurrence of hepatocellular carcinoma after percutaneous ethanol injection.
    Ishii H; Okada S; Nose H; Okusaka T; Yoshimori M; Takayama T; Kosuge T; Yamasaki S; Sakamoto M; Hirohashi S
    Cancer; 1996 May; 77(9):1792-6. PubMed ID: 8646676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anesthetic techniques and complications in patients with hepatocellular carcinoma undergoing percutaneous ethanol injection.
    Nimmaanrat S; Prechawai C; Tanomkiat W
    Minerva Anestesiol; 2007 Jun; 73(6):333-7. PubMed ID: 17589422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-resective ablation therapy for hepatocellular carcinoma: effectiveness measured by intention-to-treat and dropout from liver transplant waiting list.
    Fisher RA; Maluf D; Cotterell AH; Stravitz T; Wolfe L; Luketic V; Sterling R; Shiffman M; Posner M
    Clin Transplant; 2004 Oct; 18(5):502-12. PubMed ID: 15344951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Percutaneous ethanol injection (PEI) for small hepatocellular carcinoma].
    Ebara M; Kita K; Nagato Y; Yoshikawa M; Sugiura N; Ohto M
    Gan To Kagaku Ryoho; 1993 May; 20(7):884-8. PubMed ID: 8387759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.